Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Do I read correctly that PTSC owns ~31M shares= YES but equals 8%

There is like 400 million shares outstanding. 31 million would be around 8%.

Share
New Message
Please login to post a reply